Search Within

Karthik Nath

  1. "Population Sciences Research Program"
Formats
  1. Meeting Abstract (3)
  2. Correspondence (1)
  3. Journal Article (1)
Groups
  1. Biostatistics Service (5)
  2. Bone Marrow Transplant (5)
  3. CTCR Scholars (5)
  4. Center for Hematologic Malignancies (5)
  5. Department of Medicine (5)
  6. Epidemiology and Biostatistics (5)

More Groups

People
  1. Alexander Lesokhin (5)
  2. Andriy Derkach (5)
  3. Carlyn Rose Tan (5)
  4. David Chung (5)
  5. Gunjan Shah (5)
  6. Hani Hassoun (5)

More People

Years
  1. 2024 (3)
  2. 2023 (1)
  3. 2022 (1)
Publications
  1. Blood (2)
  2. Blood Cancer Journal (1)
  3. Clinical Lymphoma, Myeloma and Leukemia (1)
  4. Leukemia and Lymphoma (1)
Publishers
  1. American Society of Hematology (2)
  2. Elsevier Inc. (1)
  3. Nature Publishing Group (1)
  4. Taylor & Francis Group (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Infectious complications during treatment with commercial CAR T-cell therapy and bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E. M.; Shekarkhand, T.; Farzana, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R. S.; Nishimura, N.; Miller, K.; Costa, B. A.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Comparison of infectious complications with BCMA-directed therapies in multiple myeloma
    Journal Article

    Nath, K.; Shekarkhand, T.; Nemirovsky, D.; Derkach, A.; Costa, B. A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D. J.; Landau, H. J.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • A comparative analysis of infectious complications in patients with multiple myeloma treated with BCMA-targeted bispecific antibodies and CAR T-cell therapy
    Meeting Abstract

    Nath, K.; Shekarkhand, T.; Costa, B. A.; Nemirovsky, D.; Derkach, A.; Nishimura, N.; Farzana, T.; Rueda, C.; Chung, D.; Landau, H.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A short course of daratumumab in patients with multiple myeloma and minimal residual disease after induction therapy
    Correspondence

    Nath, K.; Shekarkhand, T.; Salcedo, M.; Derkach, A.; Rueda, S.; Chansakul, A.; Hulcrantz, M.; Korde, N.; Shah, U. A.; Tan, C.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save